Do you still consider surgery for N2 NSCLC in the era of consolidative immunotherapy?  

The NCCN guidelines suggest surgery can be considered for up to T3N2 NSCLC after a period of induction chemotherapy/chemo-radiation without progression. Does the PACIFIC study change your approach? 



Answer from: Medical Oncologist at Academic Institution